About: Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1985

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1985 (uk) im Juni 1985 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1985 (ast) scientific article published on 01 June 1985 (en)
publication date	wds:Q69893136-316BAE25-5A84-4047-910D-3B694C8EF81B
publication date	1985-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69893136-FFCDF01E-8894-4B64-82DF-6E6931C68687
language of work or name	English
cites work	wds:Q69893136-290889CE-FF71-4F5D-A700-6293708D36DE wds:Q69893136-41448117-675F-44CE-8361-0FA54F722100 wds:Q69893136-644294AF-2949-4FF6-A798-C8894293CA4C wds:Q69893136-6AFEB2DE-70CC-4F44-B5C0-DBCDEC623957 wds:Q69893136-905ED2EE-F7A8-4813-81B5-61D3409D9522 wds:Q69893136-9D2E50D3-20C7-486C-A307-7DAE321D2616 wds:Q69893136-B3E0A0A4-652C-450A-95FF-F5074C6C44B4 wds:Q69893136-C4665037-12AB-4B8E-8613-DA2CFABF42F7 wds:Q69893136-E4CE7AC6-D260-4A5D-9671-F97967CA9FCF
cites work	Artificial surfactant therapy in hyaline-membrane disease Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm Duration and characteristics of treatment of premature lambs with natural surfactant Surfactant function in respiratory distress syndrome Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant Dry artificial lung surfactant and its effect on very premature babies Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin
author name string	wds:Q69893136-085E9774-6D73-4126-A4AD-DE0518401E15 wds:Q69893136-32D5B391-3C21-4648-AFD5-77B4BCFAC24C wds:Q69893136-32F0F763-A4D0-4B25-B4EC-9801B687CD80 wds:Q69893136-3C64A0A6-9B79-4114-A8D9-9448E93162A0 wds:Q69893136-4EA29C0B-7CFA-4633-9557-3546A4D4A1A5 wds:Q69893136-A766C966-A2ED-4D16-B9C4-5935BCEA58BB wds:Q69893136-BC0EA1B7-9480-4180-8184-DDCE0F4D218A wds:Q69893136-C0BDEB19-55B1-4876-9966-24BF2592FBE1
author name string	T Moore T A Merritt D Edwards M Hallman L Gluck F Mannino A L Jarvenpaa B Boynton
rdfs:label	Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (en) Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (nl)
skos:prefLabel	Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (en) Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (nl)
name	Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (en) Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (nl)
title	wds:Q69893136-D9AEF855-77FE-433A-8F31-C11E9A486D17
title	Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial (en)
page(s)	wds:Q69893136-407E6585-1BC3-4688-8361-F46B106AEE5A
page(s)	963-969
instance of	wds:Q69893136-2D23A4DF-7A4A-48E3-83D2-634038555828
instance of	scholarly article
PubMed ID	wds:Q69893136-433A0426-620F-4E6E-AFE0-49015EE838DE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3889259
PubMed ID	3889259
published in	wds:Q69893136-9A71E661-8F31-474A-AB80-4D0D53FA06AC
published in	The Journal of Pediatrics
issue	wds:Q69893136-F9B41821-8F88-4B6A-A4C0-A353AE939909
volume	wds:Q69893136-973BF442-F7E4-4318-A886-4A89417BCE53
issue	6
volume	106
DOI	wds:Q69893136-934AA07B-8729-4246-A466-DDEAB9E56844
DOI	http://dx.doi.org/10.1016/S0022-3476(85)80253-5
DOI	10.1016/S0022-3476(85)80253-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69893136
is cites work of	Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention Natural vs synthetic surfactants in neonatal respiratory distress syndrome Comparison of clinical efficacy of Newfactan versus Surfacten for the treatment of respiratory distress syndrome in the newborn infants Importance of Hydrophobic Apoproteins as Constituents of Clinical Exogenous Surfactants International randomised controlled trial of patient triggered ventilation in neonatal respiratory distress syndrome Animal derived surfactant extract for treatment of respiratory distress syndrome Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups The fate of exogenous surfactant in neonates with respiratory distress syndrome Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity Factors Affecting Surfactant Responsiveness In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams Respiratory distress syndrome Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I. Respiratory distress syndrome and inositol supplementation in preterm infants High-frequency oscillatory ventilation reduces lung inflammation: a large-animal 24-h model of respiratory distress. Effects of bovine surfactant in premature lambs after intra-tracheal application Cytological changes in endotracheal aspirates associated with chronic lung disease Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure. 100 cases Effects of surfactant therapy on outcome of infants with birth weights of 600 to 750 grams Necrotizing enterocolitis in infants with very low birth weight Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants Failure of acute perinatal asphyxia or meconium aspiration to produce persistent pulmonary hypertension in a neonatal baboon model Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software